{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:16:13Z","timestamp":1772151373144,"version":"3.50.1"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,11]]},"DOI":"10.7759\/cureus.96590","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:13:41Z","timestamp":1762884821000},"source":"Crossref","is-referenced-by-count":1,"title":["Rapid Desensitization to Reslizumab in an 80-Year-Old Woman With Chronic Eosinophilic Pneumonia, Severe Persistent Asthma, and Chronic Urticaria"],"prefix":"10.7759","author":[{"given":"Vicken","family":"Khazar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Escobar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"McClain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony M","family":"Szema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S157882","article-title":"Chronic eosinophilic pneumonia: clinical perspectives","volume":"15","author":"Crowe M","year":"2019","unstructured":"Crowe M, Robinson D, Sagar M, Chen L, Ghamande S. Chronic eosinophilic pneumonia: clinical perspectives. Ther Clin Risk Manag. 2019, 15:397-403. 10.2147\/TCRM.S157882","journal-title":"Ther Clin Risk Manag"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.91817","article-title":"Chronic urticaria","volume":"56","author":"Sachdeva S","year":"2011","unstructured":"Sachdeva S, Gupta V, Amin SS, Tahseen M. Chronic urticaria. Indian J Dermatol. 2011, 56:622-8. 10.4103\/0019-5154.91817","journal-title":"Indian J Dermatol"},{"key":"ref3","unstructured":"FDA approves Cinqair to treat severe Asthma. U.S. Food and Drug Administration. https.\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-cinqair-treat-severe-asthma."},{"key":"ref4","unstructured":"Cinqair\u00ae (reslizumab) injection, for intravenous use. Initial U.S. Approval. 2016. U.S. Food and Drug Administration. (2016). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/761033lbl.pdf."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2009.04.012","article-title":"Rapid desensitization for hypersensitivity reactions to medications","volume":"29","author":"Castells M","year":"2009","unstructured":"Castells M. Rapid desensitization for hypersensitivity reactions to medications. Immunol Allergy Clin North Am. 2009, 29:585-606. 10.1016\/j.iac.2009.04.012","journal-title":"Immunol Allergy Clin North Am"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/424395-rapid-desensitization-to-reslizumab-in-an-80-year-old-woman-with-chronic-eosinophilic-pneumonia-severe-persistent-asthma-and-chronic-urticaria","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:13:42Z","timestamp":1762884822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/424395-rapid-desensitization-to-reslizumab-in-an-80-year-old-woman-with-chronic-eosinophilic-pneumonia-severe-persistent-asthma-and-chronic-urticaria"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":5,"URL":"https:\/\/doi.org\/10.7759\/cureus.96590","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,11]]}}}